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Abstract 
BACKGROUND: Oropharyngeal candidiasis is a common infection in patient receiving radiotherapy for head and neck 
cancer. Accurate and rapid identification of candida species is very important in clinical laboratory, because the  
incidence of candidiasis continues to rise after radiotherapy. The genus Candida has about 154 species that show  
different level of resistance to antifungal drugs and have high degree of phenotypic similarity. The aim of this study was 
to investigate oral yeast colonization and infection and resistance to antifungal drugs in these patients. 
METHODS: Thirty patients receiving a 6-week course of radiation therapy for treatment of head and neck cancer at the 
Oncology Unit in Shafa Hospital, in 2008, were enrolled in the study. Specimens from patients were cultured weekly 
for Candida. All isolates were plated on CHROM agar and RPMI-based medium. They were subcultured and submitted 
for antifungal susceptibility testing (nystatin, fluconazole, clotrimazole and ketoconazole) and molecular typing. 
RESULTS: Infection (clinical and microbiological evidence) occurred in 50% of the patients and Candida colonization 
(only microbiological evidence) occurred in 70% of subjects in the first week. Candida albicans alone was isolated in 
94.9% of patient visits with positive cultures. Candida tropicalis was isolated from 5.1% of patient visits with positive 
cultures. All isolates were susceptible to nystatin, but did not respond to the other antifungal drugs 
CONCLUSIONS: The irradiation-induced changes of the intraoral environment such as xerostomia lead to increased  
intraoral colonization by Candida species. All yeast isolates were susceptible to nystatin. Thus prophylactic therapy 
with nystatin should be considered for these patients. 
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atients receiving therapy for head and 
neck cancer are particularly susceptible 
to oropharyngeal candidasis.1-3 In these 
patients, radiotherapy involves oral and facial 
structure, including the major salivary glands 
that lead to prolonged xerostomia.4-6 The 
symptoms of this infection are pain and/or 
burning and can lead to significant patient 
morbidity.2 Results of past studies have shown 
that Candida albicans has been by far the most 
predominant organism isolated in patients re-
ceiving cancer therapies. Recently, an increase 
in non-Candida albicans has been reported. It 
seems that non-Candida albicans strains are 
responsible to development of resistance to 
antifungal drugs.3 However, taking a single 
culture and performing specific techniques 
may not be sensitive in distinguishing all can-
P 
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dida strains.7-9 Therefore, use of multiple cul-
tures, chromogenic medium, and molecular 
typing technique will allow the identification 
of multiple Candida species.10 
Redding and colleagues showed that Candi-
da infections occurred in 27% of 30 patients re-
ceiving radiotherapy that were predominantly 
due to Candida albicans (78%). Yeasts other 
than Candida albicans had been isolated from 
59% of patients. In this study all infections re-
sponded to fluconazole therapy.1 Leung and 
colleagues showed that irradiation-induced xe-
rostomia can lead to intraoral colonization of 
Candida species, particularly Candida albicans.6 
Antifungal drugs are used for treating fungal 
infections such as candidiasis and serious sys-
temic infections. These drugs belong to 3 prin-
cipal classes: polyenes, pyrimidines and azoles. 
Immunocompromised patients are increasingly 
susceptible to drug resistance and create poten-
tially life-threatening fungal infections.  
Resistant strains exhibit a modification in 
the quality or quantity of target enzyme, re-
duced access to the target or some combination 
of these mechanisms.9 Drug resistance depends 
on several factors including the use of inap-
propriate drugs, inadequate or excessive doses 
of medication, poor patient cooperation, quali-
ty of available drugs and geographical differ-
ences of Candida isolates. Hence, it obviously 
varies in different geographical areas.9,11 
Early diagnosis and management of oral 
candidiasis in patients receiving therapy for 
head and neck cancer is very important. Fur-
thermore, identification of Candida species has 
remained problematic because high degree of 
phenotypic similarity between candida strains 
and deciding for antifungal treatment can pose 
a problem.12,13 The aims of this study were 
evaluation of oropharyngeal Candida coloni-
zation and infection as well as resistance to an-
tifungal drugs in patients receiving radiation 
for head and neck cancer. 
Methods 
We enrolled thirty patients that received a  
6-week course of radiation therapy for treat-
ment of head and neck cancer at Shafa Hospit-
al. We examined these patients for signs of 
oropharyngeal candidiasis at baseline and 
weekly thereafter during their radiation treat-
ment, and obtained oral cultures at each visit 
and from any clinical infection. Positive clinical 
signs including white intraoral plaques, ery-
thematous lesions, ulcerations, and angular 
cheilitis, confirmed by use of 10% potassium 
hydroxid (KOH) preparation and/or positive 
culture were defined as infection. 
All fungal cultures were performed by an 
oral swab that been applied in different parts 
of the mouth and a swish sample of 10 ml of 
normal saline instilled in the mouth for 10 S 
and then collected in a sterile container. All 
swabs were tested through following tech-
niques: 
1- Direct test with KOH 10 %, to confirm the 
yeast 
2- Plate on SC medium (Sabouraud's dextrose 
agar + chloramphenicol), for Initial growth 
of yeast 
3- Plate on CMA medium (corn meal agar), to 
confirm Candida albicans 
4- Culture in human or cheap serum for three 
hours for germ tube, to supplement confirm 
of candida albicans  
5-Use of standard techniques (diagnostic kit 
and PCR-RFLP) for diagnosis of other can-
dida spices  
The PCR assay was done with 1 µL of sam-
ple (around 1ng) in a total reaction volume of 
50 µL, including of 10 mM Tris-HCL, 1.5 mM 
MgCL2, 50 mM KCL, 0.2 mM of each primers 
and 5U of Taq DNA polymerase. Thirty-five 
cycles of amplification were performed in a 
thermal cycler model Techne- progene.13 
For evaluation of antifungal drugs resistance, 
serial dilutions of all drugs  
(nystatin 100000 U/L, clotrimazole 100 mg, Ke-
toconazole 100 mg, fluconazole 100 mg), were 
prepared and minimum inhibitory concentra-
tion (MIC) were measured. First, different fungi 
were mixed with Sabouraud's dextrose agar 
and were added to plate to be solid. Then, wells 
were created in the plates, and various dilutions 
of the drugs were poured into the wells and di-
ameter of the area around them was measured. 
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All tests were repeated three times  
(triplicate) and Candida albicans was used as 
standard strain. We conducted data analysis 
using SPSS version17. We assessed the effect of 
time on Candida growth by generalized esti-
mating equations. The associations were con-
sidered statistically significant at P < 0.05. 
Results 
The demographic data (including age, sex and 
type of cancer) of the patients are shown in  
table 1. In the first week, Candida infections 
occurred in 15 of 30 patients (50%) and Candi-
da colonization occurred in 21 of 30 subjects 
(70%). The total cultures (6-week course of rad-
iation therapy) of 3 patients were negative. The 
cultures of 21 of 27 patients were positive in 
first week, and cultures of 6 of 27 subjects be-
came positive during the next weeks (Table 2).  
 
Table 1. Demographic characteristics of patients 
Characteristics Number (percent) 
Sex 
Male 
femalea 
 
18 (77.8 %) 
12 (22.2%)
Age (mean) 45.6 ± 15.6 
Site of lesion 
Larynx 
Oropharynx 
Oral cavity 
Salivary gland 
 
15 (50%) 
9 (30%) 
5 (17%) 
1 (3%)
 
Table 2. Growth of Candida in consecutive visits 
Week 
Number of patients 
1 2 3 4 5 6 
9 
2 
3 
6 
4 
3 
3 
+ 
- 
- 
+ 
- 
+ 
+ 
+ 
- 
- 
+ 
- 
+ 
+ 
+ 
- 
- 
+ 
- 
- 
- 
+ 
- 
- 
+ 
+ 
- 
- 
+ 
+ 
- 
+ 
+ 
- 
+ 
+ 
+ 
- 
_ 
+ 
- 
+ 
  - No growth of Candida 
  + Growth of Candida 
 
The results showed that time has had a signifi-
cant effect on Candida growth (P = 0.001).  
Although Candida growth in the fifth week was 
significantly higher than other weeks, there was 
not a significant relationship between Candida 
growth in other weeks (Figure 1). 
The results of PCR showed that Candida albi-
cans was detected in all of patients with posi-
tive cultures (27 subjects), and in 6 of these pa-
tients (22%) Candida albicans and Candida 
tropicalis were isolated. Overall, 118 of 180 
(65.6%) patient visits (30 visits in 6-week radia-
tion therapy) were positive for Candida car-
riage (infection and colonization). Candida al-
bicans was isolated from 112 of 180 patient vis-
its (94.9%), and Candida tropicalis with Can-
dida albicans were detected in 5.1% of patient 
visits. All infections in cultivated environments 
responded to nystatin therapy at a dosage of 
100000 U/L, but candida species did not re-
spond to other drugs. Candida species did not 
grow to 1/40 or 1/80 dilutions of nystatin in 
total cultures. There was no growth of candida 
spices to 1/160 dilution of nystatin in 3 cul-
tures after fifth and sixth weeks. 
 
 
Figure 1. The effect of time on Candida growth 
Discussion 
The epidemiology of oral candidiasis shows a 
wide variation (from 17 to 52.5%) in different 
studies.14-16 The main reason for this wide vari-
ation is the difficulty in diagnosing oral candi-
diasis (especially oral pseudomembranous 
candidiasis), from the radiation-induced mu-
cosal reaction, and the fact that oral candidiasis 
may be superimposed on radiation-induced 
mucosal reactions, causing additional prob-
lems in the differential diagnosis.14 
In the present study, positive clinical signs 
of white intraoral plaques confirmed by use of 
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10% KOH preparation and/or positive culture 
were defined as infection. Infection was re-
ported in 50% of patients after first week. Can-
dida infections were predominantly due to 
Candida albicans (94.9%), and Candida tropi-
calis was isolated in 5.1% of patient visits. The 
results of Suryawanshi and colleagues study,13 
showed that Candida albicans was seen in 
78.57%, Candida krusei in 7.15%, and Candida 
tropicalis, Candida guilliermondii, Candida 
stellatoidea and Candida parapsilosis each be-
ing 3.57%. This finding is similar to our study 
that showed Candida albicans was the predo-
minant organism. 
In other study Redding and colleagues1 
showed that Candida infections occurred in 
27% of the patients receiving radiation for 
head and neck cancer. This finding is less than 
our study, but similarly, in their study, Candi-
da albicans was the predominant organism 
(78%). The other yeasts were Candida dubli-
niensis and Candida rugosa.1 Identification of 
28 isolates at species level showed that in six 
other patients who initially had negative 
growth of Candida, the culture was positive in 
the weeks after it. This finding is similar to the 
Redding and colleagues study that showed 
Candida colonization was common and was 
detected in 73% of patients.1  
In our study PCR showed that Candida al-
bicans was detected in all of patients with posi-
tive cultures (94.8%) and in 6 of these patients 
(in 3 patients after the first and in 3 subjects 
after the fifth week) Candida tropicalis were 
also isolated. Overall, Candida tropicalis was 
isolated in 5.1% of patient visits with positive 
cultures. Redding and colleagues study 
showed that Candida albicans was the predo-
minant organism (78%), and yeasts other than 
Candida albicans (ten different species) were 
detected in 13 of 22 patients (59%) with posi-
tive cultures and at 49 of 95 patient visits with 
positive cultures (52%).1 Moreover, Leung and 
colleagues study showed that candidiasis were 
reported in 9 of 12 patients and Candida albi-
cans and Candida tropicalis were the predo-
minant organisms.6 As mentioned, the main 
reason for this variation in various studies is 
the difficulty in diagnosing oral candidiasis  
from the radiation-induced mucosal reaction. 
In this study, response to nystatin  
(100000 U/L) therapy was significant. Our 
findings showed that resistance to nystatin 
was not developed during consecutive weeks, 
even there was no growth of candida spices to 
1/160 dilution of nystatin in 3 cultures in fifth 
week. In these patients in fifth week, Candida 
tropicalis in addition to Candida albicans 
were grown, and in the sixth week following 
growth of Candida tropicalis, response to nys-
tatin therapy was created to 1/80 dilution. It 
seems that 1/40 dilution of nystatin is appro-
priate for treatment of Candida spices. 
In this study, Candida spices did not re-
spond to other drugs. Perhaps one reason for 
the lack of response is that the selected dose of 
other drugs was not sufficient. However, Red-
ding and colleagues study showed that fluco-
nazole 100 mg was effective in the treatment of 
all candida species except candida rugsa.1 
Overall, as Candida albicans was the predomi-
nant organism in our study, and response to 
nystatin therapy was significant, and resis-
tance to nystatin was not developed during 
consecutive weeks, so designing therapy pro-
grams including meeting with the dentist be-
fore radiation therapy, establishing proper oral 
hygiene status, and prescription of nystatin 
during the weeks of radiation therapy to re-
duce infections and improve quality of life for 
these patients is very effective. 
Conclusion: The irradiation-induced 
changes of the intraoral environment such as 
xerostomia, lead to increased intraoral coloni-
zation by Candida species. All isolated yeast 
were susceptible to nystatin 100000 U/L, thus 
prophylactic therapy with nystatin should be 
evaluated for these patients.  
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